Chester County News and Community Website
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), headquartered in Wayne, PA, is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that Dr. Neal Walker, CEO of Aclaris, will virtually present a company overview at the H.C. Wainwright 24th Annual Global Investment …
Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) recently announced a non-exclusive patent license agreement with Eli Lilly and Company (Lilly).
Aclaris Therapeutics Licenses Technology to Eli Lilly Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced its financial results for the second quarter of 2022 and provided a corporate update.
Aclaris Therapeutics Reports Second Quarter 2022 Financial Results Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the recent appointment of Douglas Manion, M.D., FRCP (C), as President and Chief Operating Officer. Dr. Manion will be responsible for …
Aclaris Therapeutics Expands Leadership Team Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Gail Cawkwell, MD, PhD, as Chief Medical Officer, effective June 27, 2022.
Aclaris Therapeutics Expands Leadership Team Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) states that Dr. Neal Walker, President and CEO of Aclaris, will participate in a fireside chat at the Jefferies Healthcare Conference on …
Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that Dr. Neal Walker, President and CEO of Aclaris, will virtually present a company overview at the H.C. Wainwright Global Investment …
Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced its financial results for the first quarter of 2022 and provided a corporate update.
Aclaris Therapeutics Reports First Quarter 2022 Financial Results, Provides Corporate Update Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that Dr. Neal Walker, President and CEO, and Walter Smith, Scientific and Business Development Consultant, of Aclaris will participate in a …
Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) recenlty announced its financial results for the fourth quarter and full year of 2021 and provided a corporate update.
Aclaris Therapeutics Reports Fourth Quarter, Full Year 2021 Financial Results Read More